Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avrio Health is a consumer healthcare company that specializes in the marketing and distribution of well-established over-the-counter (OTC) brands. Originally formed as a subsidiary of Purdue Pharma to manage its non-opioid consumer portfolio, the company was acquired by Arcadia Consumer Healthcare in 2023 for approximately $397 million. Its core product line includes Betadine, a leading antiseptic for infection prevention; Colace and Senokot, which are widely recognized brands for digestive health; and SlowMag Mg, a magnesium supplement. Avrio Health focuses on providing science-backed solutions for everyday health needs and maintains a significant presence in major U.S. retail channels.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Avrio.